YNBY International (HKSE:00030) ROCE % : 5.62% (As of Jun. 2024)

View and export this data going back to 1991. Start your Free Trial

What is YNBY International ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. YNBY International's annualized ROCE % for the quarter that ended in Jun. 2024 was 5.62%.

YNBY International ROCE % Historical Data

The historical data trend for YNBY International's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YNBY International ROCE % Chart

YNBY International Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Dec24

ROCE %

Get a 7-Day Free Trial

8.29

-4.37

-144.43

-96.58

13.55

YNBY International Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial															-165.96	-15.28	32.64	5.62	16.02

YNBY International ROCE % Calculation

YNBY International's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	-159.996	/	( ( (321.753 - 115.186)	+	(320.039 - 195.295) )	/ 2 )
	=	-159.996	/	( (206.567	+	124.744)	/ 2 )
	=	-159.996	/	165.6555
	=	-96.58 %

YNBY International's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Sep. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Sep. 2023 )		(Q: Jun. 2024 )
	=	11.392	/	( ( (360.258 - 208.735)	+	(345.258 - 91.052) )	/ 2 )
	=	11.392	/	( ( 151.523	+	254.206 )	/ 2 )
	=	11.392	/	202.8645
	=	5.62 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

YNBY International (HKSE:00030) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

YNBY International ROCE % Related Terms

Thank you for viewing the detailed overview of YNBY International's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

YNBY International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » YNBY International Ltd (HKSE:00030) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

979 King’s Road, 32nd Floor, Cambridge Building, Taikoo Place, Quarry Bay, Hong Kong, HKG

Website

http://www.0030.com.hk

YNBY International Ltd is a new-type comprehensive platform for international business development that serves both international and domestic clients. Centering on the health industry, its business covers E-commerce, trading, professional services and healthcare among other things. It operates entities in multiple places across the world and carries out global operations, covering Asia, America and the EMEA region. The company specializes in developing, marketing and promoting healthcare products/ services, ranging from nutraceuticals, pharmaceuticals, and functional food to cosmetics etc in the health industry.

Executives

Luo Ga	2201 Interest of corporation controlled by you
Gold Bricks Holdings Limited	2201 Interest of corporation controlled by you
Huang Bin	2201 Interest of corporation controlled by you
Citic Group Corporation	2201 Interest of corporation controlled by you
Shang Hai Guo Ji Xin Tuo You Xian Gong Si	2301 Trustee
Yun Bai Yao Xiang Gang You Xian Gong Si	2101 Beneficial owner
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si	2101 Beneficial owner
Choi Chit Sze, Jackson	2201 Interest of corporation controlled by you
Citic Limited	2201 Interest of corporation controlled by you
Citic International Financial Holdings Limited	2201 Interest of corporation controlled by you
China United International Group Limited	2201 Interest of corporation controlled by you
China Citic Bank Corporation Limited	2201 Interest of corporation controlled by you
Citic International Assets Management Limited	2201 Interest of corporation controlled by you
Sunwah Greatwall Group Limited	2101 Beneficial owner
Radiant Goldstone Holdings Limited	2201 Interest of corporation controlled by you

YNBY International Headlines

No Headlines